Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Cara Therapeutics, Inc. (NASDAQ: CARA).

Full DD Report for CARA

You must become a subscriber to view this report.


Recent News from (NASDAQ: CARA)

Cara Therapeutics to Present at the International Investigative Dermatology 2018 Meeting
STAMFORD, Conn., May 14, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today anno...
Source: GlobeNewswire
Date: May, 14 2018 16:01
Cara Therapeutics' (CARA) CEO Derek Chalmers on Q1 2018 Results - Earnings Call Transcript
Cara Therapeutics Inc. (CARA) Q1 2018 Results Earnings Conference Call May 09, 2018, 04:30 PM ET Executives Michael Schaffzin - IR, Stern Investor Relations Derek Chalmers - President & Chief Executive Officer Mani Mohindru - Chief Financial Officer and Chief Strategy Officer...
Source: SeekingAlpha
Date: May, 09 2018 18:34
Cara Therapeutics Reports First Quarter 2018 Financial Results
STAMFORD, Conn., May 09, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today anno...
Source: GlobeNewswire
Date: May, 09 2018 16:01
Cara Therapeutics to Announce First Quarter 2018 Financial Results on May 9, 2018
STAMFORD, Conn., May 02, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today anno...
Source: GlobeNewswire
Date: May, 02 2018 16:30
Research Report Identifies Cara Therapeutics, MGE Energy, IDEXX Laboratories, Sterling Construction, TTM Technologies, and Regis with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement
NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cara Therapeutics, Inc. (NASDAQ:CARA), MGE Energy Inc. (NASDAQ:MGEE), ID...
Source: GlobeNewswire
Date: April, 30 2018 08:15
Opioid prescriptions dropped 12% in 2017
Opioid prescriptions dropped 12% in 2017, according to a report from the IQVIA Institute for Human Data Science. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Industries Limited, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: April, 26 2018 03:18
3 Things In Biotech, April 13: Roche Pipes Up, Cara Updates, Bellicum Marches On
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we're talking about! Welcome to another edition of "3 Things In Biotech," a daily digest dedicated to helping you keep pace with the fast-moving worl...
Source: SeekingAlpha
Date: April, 14 2018 08:00
Cara Therapeutics Announces Participation in 2018 Spring Clinical Meetings of the National Kidney Foundation
STAMFORD, Conn., April 10, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today an...
Source: GlobeNewswire
Date: April, 10 2018 07:00
Research Report Identifies Preferred Apartment Communities, Ubiquiti Networks, Infinity Property and Casualty, Cara Therapeutics, BP Prudhoe Bay Royalty Trust, and Mesabi Trust with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Preferred Apartment Communities, Inc. (NYSE:APTS), Ubiquiti Networks, In...
Source: GlobeNewswire
Date: March, 22 2018 07:35
Blog Exposure - Inovio Pharma Closed Collaboration Deal with ApolloBio to Develop and Commercialize VGX-3100 in Greater China
Stock Monitor: Cara Therapeutics Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 22, 2018 / Active-Investors.com has just released a free research report on Inovio Pharma, Inc. (NASDAQ: INO ). If you want access to this report all you need to do is sign up now by clicking the...
Source: ACCESSWIRE IA
Date: March, 22 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1812.4012.3912.4512.15367,636
2018-05-1712.4012.3912.4512.15367,636
2017-02-0316.2216.6516.7515.852,522,041
2017-02-0216.5415.8416.989914.043,951,113
2017-02-0115.6116.4917.2015.35014,734,647

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-25951,3852,084,35545.6441Short
2018-05-24929,2961,934,89848.0282Short
2018-05-233,317,6277,182,49846.1904Short
2018-05-22162,674253,60464.1449Short
2018-05-21370,186488,21475.8245Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CARA.


About Cara Therapeutics, Inc. (NASDAQ: CARA)

Logo for Cara Therapeutics, Inc. (NASDAQ: CARA)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: CARA)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 09 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 09 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 26 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 26 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 16 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 15 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: March, 15 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 12 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 14 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 09 2018

       

       


      Daily Technical Chart for (NASDAQ: CARA)

      Daily Technical Chart for (NASDAQ: CARA)


      Stay tuned for daily updates and more on (NASDAQ: CARA)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: CARA)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      OTC Report
      @OTCReporter

       

       


      Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CARA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CARA and does not buy, sell, or trade any shares of CARA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/